MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Substance Abuse, Substance Use Disorder (SUD)_Opioid, Alcohol, Tobacco, Etc.
Indivior PLC (OTCPK: INVVY), (NASDAQ: INDV)
Organization & Developments: Indivior
Parents
Indivior PLC (OTCPK: INVVY), (NASDAQ: INDV)
Children
*Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders.
*The company operates in approximately 40 countries worldwide.
*The company’s product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia.
2024: Indivior PLC 2023 Q4 - Results - Earnings Call Presentation
2024: Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025
Jumps
Finance & Acquisitions: Indivior
Key People: Indivior